University of Leeds

Alnylam CEO Yvonne Greenstreet Named 2024 Woman of the Year by Healthcare Businesswomen’s Association

Retrieved on: 
Tuesday, January 9, 2024

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, said today that Chief Executive Officer Yvonne Greenstreet has been selected as the 2024 Woman of the Year by the Healthcare Businesswomen’s Association (HBA).

Key Points: 
  • Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, said today that Chief Executive Officer Yvonne Greenstreet has been selected as the 2024 Woman of the Year by the Healthcare Businesswomen’s Association (HBA).
  • Yvonne will be recognized at HBA’s 34th annual Woman of the Year event on May 10 in New York City.
  • The HBA Woman of the Year award honors an executive leader who has made extraordinary contributions to healthcare and the advancement of women in the workplace.
  • “Yvonne demonstrates leadership from the front,” said David Pyott, retired chairman and CEO of Allergan and a member of Alnylam’s board of directors.

Levicept Completes Recruitment in Phase II Clinical Trial of Neurotrophin Modulator LEVI-04

Retrieved on: 
Wednesday, December 13, 2023

The multiple-arm, multicentre, prospective, randomized, double-blind, placebo-controlled Phase II study enrolled more than 500 participants with pain due to osteoarthritis of the knee ( ClinicalTrials.gov ID: NCT05618782 ).

Key Points: 
  • The multiple-arm, multicentre, prospective, randomized, double-blind, placebo-controlled Phase II study enrolled more than 500 participants with pain due to osteoarthritis of the knee ( ClinicalTrials.gov ID: NCT05618782 ).
  • The trial was designed to evaluate the efficacy, safety and tolerability of five, monthly, infusions of LEVI-04 as compared to placebo in participants with radiographic and symptomatic knee osteoarthritis.
  • It operates across four receptor pathways in the neurotrophin system and is designed to supplement the existing endogenous p75NTR binding protein and returning normal neurotrophin function.
  • While the potential of the neurotrophin pathway to provide effective pain relief is recognised, safety issues have significantly hampered development.

4Moving Biotech forms its Scientific Advisory Board of World-Renowned Knee Osteoarthritis Experts

Retrieved on: 
Friday, November 10, 2023

4Moving Biotech, a subsidiary of 4P-Pharma, announces establishing an international Scientific Advisory Board in anticipation of its knee osteoarthritis drug candidate's phase 2b clinical trial.

Key Points: 
  • 4Moving Biotech, a subsidiary of 4P-Pharma, announces establishing an international Scientific Advisory Board in anticipation of its knee osteoarthritis drug candidate's phase 2b clinical trial.
  • Professor Francis Berenbaum, CMO of 4Moving Biotech, will lead the work of this scientific advisory board.
  • The Scientific Advisory Board will bring deep knowledge and experience from clinical research, academia, and industry to better serve people suffering from knee osteoarthritis.
  • 4Moving Biotech has responded to this challenge with an innovative research program to explore the potential of intra-articular GLP-1 analogs for knee osteoarthritis treatment.

WeTrade Group Inc. Announces Change of Board of Directors and Senior Management

Retrieved on: 
Thursday, September 28, 2023

With these changes, the Board of the Company comprises three directors: Mr. Zheng Dai, Mr. Daxue Li and Mr. Xianzhi Liu.

Key Points: 
  • With these changes, the Board of the Company comprises three directors: Mr. Zheng Dai, Mr. Daxue Li and Mr. Xianzhi Liu.
  • Mr. Zheng Dai, 48, is the founder of the Company, co-founder of Qunar.com, and has achieved significant recognition in the field of internet marketing.
  • In 2019, Mr. Dai founded the Company and served as the chairman until his resignation on December 21, 2022.
  • Ms. Lina Jiang, 46, has over 20 years of work experience and has held core management positions at various companies.

MicroPort Orthopedics Releases Renowned Speaker Lineup for Second Annual Global Medial-Pivot Symposium

Retrieved on: 
Wednesday, September 20, 2023

ARLINGTON, Tenn., Sept. 20, 2023 /PRNewswire/ -- MicroPort Orthopedics, a global leader in Medial-Pivot Knee Technology, today announces the full agenda and line-up of world-renowned surgeons speaking at its second annual Global Medial-Pivot Symposium, October 13-14, 2023, in Phoenix, Arizona. This event will highlight the Evolution® Medial-Pivot knee design principles and scientific evidence, personalized surgical approaches including alignment strategies, advanced digital technologies, and improved patient care pathways. The two-day educational event will include faculty-led discussions, an evening event celebrating the 25th anniversary of the Medial-Pivot technology, and engaging breakout sessions.

Key Points: 
  • ARLINGTON, Tenn., Sept. 20, 2023 /PRNewswire/ -- MicroPort Orthopedics , a global leader in Medial-Pivot Knee Technology, today announces the full agenda and line-up of world-renowned surgeons speaking at its second annual Global Medial-Pivot Symposium , October 13-14, 2023, in Phoenix, Arizona.
  • This event will highlight the Evolution ® Medial-Pivot knee design principles and scientific evidence, personalized surgical approaches including alignment strategies, advanced digital technologies, and improved patient care pathways.
  • We're excited to come together to explore the most innovative developments in our industry," said symposium steering committee chair Lowry Barnes, MD.
  • MicroPort Orthopedics offers various products and techniques to help patients receiving total hip and knee replacements achieve Full Function, Faster®.

Higher Education Market size worth USD 853.28 Billion, Globally, by 2030 at 7.03% CAGR: Verified Market Research®

Retrieved on: 
Wednesday, September 6, 2023

JERSEY CITY, N.J., Sept. 6, 2023 /PRNewswire/ -- The Global Higher Education Market is projected to grow at a CAGR of 7.03% from 2023 to 2030, according to a new report published by Verified Market Research®. The report reveals that the market was valued at USD 477.12 Billion in 2022 and is expected to reach USD 853.28 Billion by the end of the forecast period.

Key Points: 
  • The report provides an in-depth analysis of the global Higher Education Market, including its growth prospects, market trends, and market challenges.
  • The global Higher Education Market, characterized by post-secondary and tertiary education institutions, is undergoing a significant transformation.
  • To get market data, market insights, financial statements and a comprehensive analysis of the Global Higher Education Market, please Contact Verified Market Research® .
  • Based on the research, Verified Market Research® has segmented the global Higher Education Market into Course, Institution, Mode, And Geography.

Higher Education Market size worth USD 853.28 Billion, Globally, by 2030 at 7.03% CAGR: Verified Market Research®

Retrieved on: 
Wednesday, September 6, 2023

JERSEY CITY, N.J., Sept. 6, 2023 /PRNewswire/ -- The Global Higher Education Market is projected to grow at a CAGR of 7.03% from 2023 to 2030, according to a new report published by Verified Market Research®. The report reveals that the market was valued at USD 477.12 Billion in 2022 and is expected to reach USD 853.28 Billion by the end of the forecast period.

Key Points: 
  • The report provides an in-depth analysis of the global Higher Education Market, including its growth prospects, market trends, and market challenges.
  • The global Higher Education Market, characterized by post-secondary and tertiary education institutions, is undergoing a significant transformation.
  • To get market data, market insights, financial statements and a comprehensive analysis of the Global Higher Education Market, please Contact Verified Market Research® .
  • Based on the research, Verified Market Research® has segmented the global Higher Education Market into Course, Institution, Mode, And Geography.

TECNO and School of Design at University of Leeds Announce Partnership to Advance Innovations in Inclusive Multi-Skin Tone Imaging System on Smartphones

Retrieved on: 
Thursday, August 10, 2023

LONDON, Aug. 10, 2023 /PRNewswire/ -- TECNO, a global pioneer in inclusive camera technology, today announced a strategic partnership with the School of Design at University of Leeds to jointly advance the application of colour science to TECNO's multi-skin tone imaging system, which is to ultimately empower the imaging experience especially portrait on TECNO's smartphones and strengthen its unique leadership across the industry. With in-depth academic research, scientific analysis and consultation from authoritative experts in the field, the partnership aims to break down barriers to achieve more realistic true-to-life portrait imaging that results in a more inclusive photography experience for smartphone users of every skin tone from TECNO's target markets.

Key Points: 
  • This strategic partnership will leverage TECNO's cutting-edge technological capabilities and the School of Design at University of Leeds' colour science expertise to further solidify TECNO's position as a flag-bearer for smartphones designed with every skintone in mind.
  • The collaboration will focus on delivering scientific research and breakthroughs that advance multi-skin tone portrait imaging technology in smartphones.
  • "TECNO has always seen portrait photography as an important opportunity to promote greater inclusivity in smartphone technology," said Jack Guo, General Manager of TECNO.
  • With this consumer-centric approach and market-driven strategy, TECNO is well-positioned to continue leading innovation in the industry through this new strategic partnership.

TECNO and School of Design at University of Leeds Announce Partnership to Advance Innovations in Inclusive Multi-Skin Tone Imaging System on Smartphones

Retrieved on: 
Thursday, August 10, 2023

LONDON, Aug. 10, 2023 /PRNewswire/ -- TECNO, a global pioneer in inclusive camera technology, today announced a strategic partnership with the School of Design at University of Leeds to jointly advance the application of colour science to TECNO's multi-skin tone imaging system, which is to ultimately empower the imaging experience especially portrait on TECNO's smartphones and strengthen its unique leadership across the industry. With in-depth academic research, scientific analysis and consultation from authoritative experts in the field, the partnership aims to break down barriers to achieve more realistic true-to-life portrait imaging that results in a more inclusive photography experience for smartphone users of every skin tone from TECNO's target markets.

Key Points: 
  • This strategic partnership will leverage TECNO's cutting-edge technological capabilities and the School of Design at University of Leeds' colour science expertise to further solidify TECNO's position as a flag-bearer for smartphones designed with every skintone in mind.
  • The collaboration will focus on delivering scientific research and breakthroughs that advance multi-skin tone portrait imaging technology in smartphones.
  • "TECNO has always seen portrait photography as an important opportunity to promote greater inclusivity in smartphone technology," said Jack Guo, General Manager of TECNO.
  • By creating stylish, intelligent products, TECNO inspires consumers worldwide to never stop pursuing their best selves and their best futures.

Yes, AI could help us fix the productivity slump – but it can’t fix everything

Retrieved on: 
Wednesday, June 21, 2023

So it’s not surprising some see the rise of artificial intelligence (AI) as productivity’s saviour.

Key Points: 
  • So it’s not surprising some see the rise of artificial intelligence (AI) as productivity’s saviour.
  • Media articles herald a new era of high productivity enabled by AI, and particularly by generative AI tools such as ChatGPT and DALL-E.
  • Similarly, the world’s top journals are filled with accounts of how AI has enabled transformative leaps in research.

Not a productivity panacea

    • These are the cases, often not captured in journals and media, where using AI has been costly and time-consuming and failed to generate the desired result.
    • That’s not to say AI can’t be used to boost productivity – just that it isn’t an off-the-shelf panacea to our productivity woes.
    • This will hardly lead to a productivity gain.

Where AI applications work

    • In Australia, Westpac says AI has provided a 46% productivity increase for its software engineers, with no loss in quality of work.
    • It’s obvious AI can boost productivity when used effectively; Google Maps is clearly better at getting someone from A to B than an old road atlas.
    • Successful applications of AI tend to be characterised by a clear need and function for the AI system.

Where AI applications fail

    • Consulting firm Deloitte estimates 70% of organisations’ digital transformation efforts fail.
    • Perhaps the real solution to the productivity dilemma lies less in using AI, and more in managing the organisational inefficiencies associated with adopting new technology.
    • The currency of the modern day is attention; an AI that’s built to shield us from unnecessary busywork may end up nagging us.
    • We may even see a future where AI tools designed to shield us from distraction are competing with AI tools designed to distract us.

Towards long-term productivity gains

    • It seems very likely AI will improve productivity at a societal level in the long run, and some of these improvements may be transformative.
    • As of September 2022, research found 5.7% of all peer-reviewed research published worldwide was on the topic of AI – up from 3.1% in 2017, and 1.2% in 2000.
    • It’s clear innovators everywhere are exploring how AI can supercharge their productivity – and perhaps help them make discoveries.